Posts Tagged ‘Multiple Sclerosis’

BG-12: The Changing Landscape of Multiple Sclerosis Therapy

Posted by • September 19th, 2012

Multiple sclerosis (MS) remains a leading cause of neurologic disability in the young.  MS usually relapses and remits before entering a progressive phase. We still don’t know the precipitating cause of MS – consequently we have no cure.  Our best approach right now is to try to reduce relapse rate by using drugs that we… Read More…

Fingolimod in Multiple Sclerosis

Posted by • January 26th, 2012

In the latest article in our Clinical Therapeutics review series, Fingolimod for Multiple Sclerosis, a 37-year-old man with multiple sclerosis has recurrent disease activity despite several previous therapies. Treatment with fingolimod is recommended. Fingolimod blocks the egress of lymphocytes from lymph nodes, preventing them from reaching the central nervous system. Multiple sclerosis is an inflammatory, central… Read More…